Literature DB >> 25015869

Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Seth C Lummus1, Dara L Aisner1, Sharon B Sams1, Nicholas K Foreman2, Kevin O Lillehei3, B K Kleinschmidt-DeMasters4.   

Abstract

OBJECTIVES: Metastatic leptomeningeal spread from spinal cord gangliogliomas (GGs) is exceedingly rare.
METHODS: Two adult women, aged 27 and 51 years, died of massive disseminations of cervicothoracic GGs 4 and 6 years, respectively, after initial diagnoses; full autopsies were performed. BRAF status was assessed by VE1 immunohistochemistry (IHC), Sanger sequencing, and a single-nucleotide base extension assay (SNaPshot, Applied Biosystems, Princeton, NJ).
RESULTS: The 27-year-old underwent two biopsies, chemotherapy, radiation, and ventriculoperitoneal shunt placement; she developed craniospinal and peritoneal dissemination. Autopsy confirmed shunt-mediated peritoneal metastases, microscopic bone marrow involvement, and profuse spinal and supratentorial leptomeningeal and parenchymal spread. The 51-year-old underwent two resections, radiation, and chemotherapy and developed pancytopenia with biopsy-proven bony metastases 15 months before death. Autopsy demonstrated leptomeningeal, subpial, and subependymal metastases. The tumors in both primary and metastatic sites were BRAF negative by VE1 IHC and two different mutational analyses. This compared with negative BRAF results for an additional four nonmetastatic adult nonsupratentorial GGs and in our study.
CONCLUSIONS: We document two rare cases of massively metastatic spinal cord GGs in adult patients who were negative for BRAF V600E mutations via multiple methods. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  BRAF V600E; Bone marrow; Ganglioglioma; Intramedullary; Metastasis; Spinal cord; VE1

Mesh:

Substances:

Year:  2014        PMID: 25015869      PMCID: PMC4616006          DOI: 10.1309/AJCPIBSV67UVJRQV

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  25 in total

1.  Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells.

Authors:  Christian Koelsche; Adelheid Wöhrer; Astrid Jeibmann; Jens Schittenhelm; Genevieve Schindler; Matthias Preusser; Felix Lasitschka; Andreas von Deimling; David Capper
Journal:  Acta Neuropathol       Date:  2013-02-24       Impact factor: 17.088

2.  Ganglioglioma of the spinal cord. A case with a long survival.

Authors:  G Bevilacqua; R Sarnelli
Journal:  Acta Neuropathol       Date:  1979-12       Impact factor: 17.088

3.  Surgical pathology of intramedullary spinal cord neoplasms.

Authors:  D C Miller
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

4.  Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

Authors:  Yao Schmidt; B K Kleinschmidt-DeMasters; Dara L Aisner; Kevin O Lillehei; Denise Damek
Journal:  J Neurooncol       Date:  2012-10-25       Impact factor: 4.130

5.  Central nervous system neoplasm in a young man with Martin-Bell syndrome--fra(X)-XLMR.

Authors:  L Rodewald; D C Miller; L Sciorra; G Barabas; M L Lee
Journal:  Am J Med Genet       Date:  1987-01

6.  Spinal cord gangliogliomas: a review of 56 patients.

Authors:  George I Jallo; Diana Freed; Fred J Epstein
Journal:  J Neurooncol       Date:  2004-05       Impact factor: 4.130

7.  Leptomeningeal dissemination in children with progressive low-grade neuroepithelial tumors.

Authors:  Juliette Hukin; Joao Siffert; Linda Velasquez; David Zagzag; Jeffrey Allen
Journal:  Neuro Oncol       Date:  2002-10       Impact factor: 12.300

8.  Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Authors:  Bette Kay Kleinschmidt-DeMasters; Dara L Aisner; Diane K Birks; Nicholas K Foreman
Journal:  Am J Surg Pathol       Date:  2013-05       Impact factor: 6.394

9.  Ganglioglioma: a correlative clinicopathological and radiological study of ten surgically treated cases with follow-up.

Authors:  U P Kalyan-Raman; W C Olivero
Journal:  Neurosurgery       Date:  1987-03       Impact factor: 4.654

Review 10.  What do we know about IDH1/2 mutations so far, and how do we use it?

Authors:  Craig Horbinski
Journal:  Acta Neuropathol       Date:  2013-03-20       Impact factor: 15.887

View more
  4 in total

1.  BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.

Authors:  Bette K Kleinschmidt-DeMasters; Dara L Aisner; Nicholas K Foreman
Journal:  Am J Surg Pathol       Date:  2015-04       Impact factor: 6.394

2.  Genetic Characterization of a Multifocal Ganglioglioma Originating Within the Spinal Cord.

Authors:  Joshua L Wang; Christopher S Hong; Jose Otero; Vinay K Puduvalli; J Bradley Elder
Journal:  World Neurosurg       Date:  2016-09-23       Impact factor: 2.104

Review 3.  Practical aspects regarding the histopathological grading and anaplastic transformation of gangliogliomas - a literature review.

Authors:  Antonia Carmen Lisievici; Mihai Gheorghe Lisievici; Diana Paşov; Tiberiu Augustin Georgescu; Octavian Munteanu; Corina Grigoriu; Roxana Elena Bohîlţea; Florentina Ligia Furtunescu; Maria Sajin
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

4.  Indolent enhancing spinal lesions mimicking spinal metastasis in pediatric patients with malignant primary brain tumors.

Authors:  Hsin-Wei Wu; Shih-Chieh Lin; Ching-Lan Wu; Kang-Lung Lee; Chia-Hung Wu; Shu-Ting Chen; Hsin-Hung Chen; Yi-Yen Lee; Yi-Wei Chen; Chih-Chun Wu; Ting-Rong Hsu; Feng-Chi Chang
Journal:  Sci Rep       Date:  2022-02-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.